Table 2 Right heart function and morphology in NETs
From: Prevalence, one-year-incidence and predictors of carcinoid heart disease
Baseline | Twelve-month follow-up | P-value | |
|---|---|---|---|
RVOT-VTI, cm (IQR) | 15 (13–16) | 14 (12–18) | 0.937 |
TAPSE, mm ± SD | 24 ± 4 | 25 ± 5 | 0.202 |
RV-Sʹ, cm/s (IQR) | 13 (11–14) | 13 (11–15) | 0.500 |
MPEI (IQR) | 0.45 (0.37–0.56) | 0.42 (0.36–0.53) | 0.959 |
Free wall RV strain, % ± SD | -27.3 ± 5.8, n = 30 | -28.1 ± 7.2, n = 30 | 0.581 |
Global RV strain, % ± SD | -21.7 ± 4.9, n = 30 | -22.5 ± 5.7, n = 30 | 0.478 |
RVD basal, mm ± SD | 32 ± 7 | 34 ± 7 | 0.094 |
RVD mid, mm ± SD | 25 ± 7 | 25 ± 7 | 0.872 |
RV apex-base, mm ± SD | 73 ± 10 | 63 ± 11 | 0.020 |
RVOT1, mm ± SD | 31 ± 4 | 30 ± 4 | 0.282 |
RVOT2, mm ± SD | 23 ± 4 | 24 ± 4 | 0.392 |
RA area, cm2 (IQR) | 13 (11–16) | 14 (12–17) | 0.112 |